Skip to main content
Premium Trial:

Request an Annual Quote

DSM Leads Sequencing of Aspergillus niger Genome

NEW YORK (GenomeWeb News) - Dutch industrial chemical firm DSM has completed a collaborative project to sequence the genome of Aspergillus niger CBS 513.88, a microorganism that DSM uses to produce enzymes and other compounds.
DSM and its collaborators are publishing the results of the sequencing project in the February issue of Nature Biotechnology. DSM said 29 other research institutions participated in the study.
The A. niger genome has around 33.9 million base pairs with more than 14,000 unique genes. The functions of as many as 6,500 of these genes may be discovered, the company said.
The project has so far spurred “numerous” DSM patent applications, DSM said, including products such as one for muscular recovery, an enzyme to prevent ‘chill-haze’ in beer, and an enzyme to prevent formation of a toxic compound in some fried foods.
The company said the project resulted in several new collaborations with companies such as Gene Alliance, Biomax, Affymetrix, the University of Amsterdam, and others.

The Scan

Comfort of Home

The Guardian reports that AstraZeneca is to run more clinical trials from people's homes with the aim of increasing participant diversity.

Keep Under Control

Genetic technologies are among the tools suggested to manage invasive species and feral animals in Australia, Newsweek says.

Just Make It

The New York Times writes that there is increased interest in applying gene synthesis to even more applications.

Nucleic Acids Research Papers on OncoDB, mBodyMap, Genomicus

In Nucleic Acids Research this week: database to analyze large cancer datasets, human body microbe database, and more.